The Most Popular Social Media Platforms in the Pharma Industry for 2017 & 2018

Print 17 August 2017
Market Wire

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 09, 2017) - A new study of pharmaceutical marketing teams found that the most popular social media forum groups plan to use in the next one to two years is Facebook (73%), according to data published by business intelligence firm Cutting Edge Information.

Data found in the study, Pharmaceutical Marketing: Reevaluate Digital Trends and Metrics for Social Media and Mobile Success, which was published less than a month ago, revealed that YouTube (64%) and LinkedIn (55%) are also common for surveyed life science marketing teams, with Twitter (45%) at a more distant fourth.

Not as popular, but still commonly used social networking sites include Instagram and Tumblr, with 18% and 9% of pharmaceutical marketing teams utilizing them, respectively. Additional data from the study show that no surveyed pharmaceutical and medical device companies report using Pinterest, Vine, Flickr and Reddit.

"New technology offers many opportunities in the pharmaceutical industry," said Natalie DeMasi, research team leader at Cutting Edge Information. "As a result, social media and mobile platforms are becoming more and more a part of teams' digital strategies."

Cutting Edge Information's study, Pharmaceutical Marketing: Reevaluate Digital Trends and Metrics for Social Media and Mobile Success, available at https://www.cuttingedgeinfo.com/product/pharmaceutical-marketing/, explores the specific objectives, platforms and ROI metrics that life science teams employ in digital marketing. This report features analysis of exciting and potentially concerning up-and-coming trends in the digital marketing space.

Source

Return

All Partners

All Portfolio

MEDIA CENTER

  • NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the start of construction of a plant for the production of sterile injectable drugs as part of its long-term strategy to localize innovative medicines and technologies of their development and production in Russia. The plant will be built in the industrial park “Vorsino” in the Kaluga region.

All news